🇺🇸 FDA
Pipeline program

Molecular imaging with FAPI for diagnosing the CSM4 colorectal cancer subtype

U23-0607

Phase 1 other active

Quick answer

Molecular imaging with FAPI for diagnosing the CSM4 colorectal cancer subtype for Colorectal cancer, liver metastases is a Phase 1 program (other) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
Colorectal cancer, liver metastases
Phase
Phase 1
Modality
other
Status
active

Clinical trials